Thrivent Financial for Lutherans’s Adaptive Biotechnologies ADPT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$384K	Sell	27,670 -10,264	-27%	-$164K	﹤0.01%	2302
2025 Q4	$618K	Buy	+37,934	New	+$619K	﹤0.01%	2169
2023 Q3	–	Sell	-42,435	Closed	-$285K	–	2429
2023 Q2	$285K	Sell	42,435 -2,082	-5%	-$15.5K	﹤0.01%	2335
2023 Q1	$393K	Sell	44,517 -248,226	-85%	-$2.19M	﹤0.01%	2217
2022 Q4	$2.24M	Buy	292,743 +4,196	+1%	+$32.6K	0.01%	1183
2022 Q3	$2.05M	Buy	288,547 +13,787	+5%	+$130K	0.01%	1200
2022 Q2	$2.22M	Sell	274,760 -18,196	-6%	-$160K	0.01%	1174
2022 Q1	$4.07M	Sell	292,956 -294,814	-50%	-$4.64M	0.01%	962
2021 Q4	$16.5M	Buy	587,770 +24,508	+4%	+$751K	0.03%	524
2021 Q3	$19.1M	Buy	563,262 +14,086	+3%	+$509K	0.04%	476
2021 Q2	$22.4M	Buy	549,176 +111,051	+25%	+$4.32M	0.05%	426
2021 Q1	$17.6M	Buy	+438,125	New	+$23.7M	0.04%	483
2020 Q4	–	Hold	0	–	–	–	2153